Development and qualification of an automated capillary Western method for the identification of polysaccharide

Alyssa Deiss1, John W Loughney1, Richard R Rustandi1

  • 1Analytical Research Development, Merck & Co., Inc., Rahway, NJ, USA.

Insights

A new assay accurately identifies individual polysaccharides in Pneumococcal conjugate vaccines (PCVs). This quality control method ensures vaccine efficacy and safety for adults and infants against Streptococcus pneumoniae infections.

Area of Science:

  • Vaccinology
  • Analytical Chemistry
  • Microbiology

Background:

  • Streptococcus pneumoniae infections pose significant mortality risks in adults and infants.
  • Pneumococcal conjugate vaccines (PCVs) are crucial for disease prevention.
  • Accurate identification of polysaccharide serotypes in multi-valent PCVs is essential for quality control.

Purpose of the Study:

  • To develop and qualify an analytical assay for identifying individual polysaccharide components in multi-valent PCVs.
  • To ensure the quality and consistency of PCV products, including Vaxneuvance™.

Main Methods:

  • Development of an identity assay utilizing an automated capillary western system (Simple Western).
  • Implementation of a multi-valent system suitability sample (SSS) for determining individual polysaccharide components.
  • Rigorous analytical development and optimization of the assay.

Main Results:

  • The developed Simple Western assay successfully identified individual polysaccharide components within a multi-valent PCV.
  • The assay was qualified for use in the clinical release of PCVs.
  • Demonstrated high efficacy of PCVs for adult and pediatric doses.

Conclusions:

  • The automated capillary western system provides a robust method for PCV identity testing.
  • This assay is critical for ensuring the quality attribute of specific polysaccharide identification in complex vaccine formulations.
  • The qualified assay supports the clinical release of PCVs, contributing to public health efforts against pneumococcal disease.